Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agent (Q53724501)
scientific article
Language:
Current Data About Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agent
(P31) (Q13442814)
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

(P304) 195-200
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

(P407) (Q1860)

(P433) 2
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

(P478) 103
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

(P577) Thursday, August 1, 1985
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

(P921) (Q181600)

(Q29496)
(P887)

(Q18556145)
(P887)

(P1433) (Q564416)
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

(P1476) "Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agent" (language: en)
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

(P2093) Pedersen-Bjergaard J
(P1545) 1
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

Ersbøll J
(P1545) 2
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

Sørensen HM
(P1545) 3
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

Keiding N
(P1545) 4
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

Larsen SO
(P1545) 5
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

Philip P
(P1545) 6
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

Larsen MS
(P1545) 7
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

Schultz H
(P1545) 8
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

Nissen NI
(P1545) 9
(P248)
(P698) 4014901
(P813) Friday, May 18, 2018
(P854) http://europepmc.org/abstract/MED/4014901

other details
description scientific article

External Links
(P356) 10.7326/0003-4819-103-2-195
(P698) 4014901